Provenienza dei contatti di primo grado di Peiqi Sun
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Silicon INSITE, Inc.
Silicon INSITE, Inc. BiotechnologyHealth Technology Silicon Therapeutics LLC operates as an integrated computational drug discovery company that focuses on developing novel medicines for diseases. Its INSITE platform closely represents the dynamical nature of targets using all-atom simulations. The firm has offices in Boston and Shanghai. The company was founded by Lijun Sun, Peiqi Sun, Elliot L. Chaikof, and Finith Jernigan, III in 2016 and is headquartered in Boston, MA.
8
| Subsidiary | Biotechnology | 8 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Peiqi Sun tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Immunex Corp.
Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Biotechnology | Chief Tech/Sci/R&D Officer | |
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Janssen R&D Ireland Ltd. | President | ||
CommonHealth
CommonHealth Advertising/Marketing ServicesCommercial Services CommonHealth provides marketing and advertising services to the healthcare industry. Its services include market research, advertising, strategic planning and media planning. The company represents both domestic and global brands of leading healthcare manufacturers and marketers. CommonHealth was founded in 1974 and is headquartered in Parsippany, NJ. | Advertising/Marketing Services | Comptroller/Controller/Auditor | |
XINJIANG BAI HUA CUN PHARMA TECH CO.,LTD | Miscellaneous Commercial Services | Director/Board Member | |
Stony Brook University | College/University | Doctorate Degree | |
The Johns Hopkins University | College/University | Undergraduate Degree | |
University of Iowa | College/University | Undergraduate Degree | |
Georgetown University | College/University | Graduate Degree | |
Beth Israel Deaconess Medical Center, Inc.
Beth Israel Deaconess Medical Center, Inc. Hospital/Nursing ManagementHealth Services Beth Israel Deaconess Medical Center provides medical services. It offers patient care, biomedical research, teaching, and community services. It also provides organ transplantation, breast cancer care, and cardiac surgery services. The company was founded in 1896 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal Director/Board Member | |
Shanghai Jiao Tong University | College/University | Undergraduate Degree | |
Jilin University | College/University | Graduate Degree | |
Hongshan
Hongshan Investment ManagersFinance Hongshan (Hongshan) is a venture and private equity is a subsidiary of SEQUOIA CAPITAL OPERATIONS LLC founded in 2005. The firm headquartered in Hong Kong. | Investment Managers | Private Equity Investor | |
Bayer HealthCare Pharmaceuticals, Inc.
Bayer HealthCare Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Bayer HealthCare Pharmaceuticals, Inc. manufactures pharmaceutical drugs. It offers pharmaceuticals and therapeutics in the areas of diagnostic imaging, hematology and cardiology, cancer, women's health and several other chronic diseases such as multiple sclerosis and Parkinson's disease. Bayer HealthCare Pharmaceuticals was founded in 1979 and is located in Wayne, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Shionogi Bioresearch Corp. | Corporate Officer/Principal | ||
Berlex Pharmaceuticals, Inc. | Corporate Officer/Principal | ||
CONTRAFECT CORPORATION | Biotechnology | Chief Executive Officer | |
Harvard Medical School | College/University | Corporate Officer/Principal | |
China Pharmaceutical University | College/University | Doctorate Degree | |
SERES THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer | |
TOT BIOPHARM INTERNATIONAL COMPANY LIMITED | Pharmaceuticals: Major | Director/Board Member | |
The Johns Hopkins University School of Medicine | College/University | Doctorate Degree | |
JUNO THERAPEUTICS INC | Biotechnology | Chief Tech/Sci/R&D Officer | |
University of Iowa Carver College of Medicine | College/University | Doctorate Degree | |
EVELO BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member | |
Xuzhou Medical University | College/University | Graduate Degree | |
Harbour BioMed (Shanghai) Co., Ltd.
Harbour BioMed (Shanghai) Co., Ltd. BiotechnologyHealth Technology Harbour Biomed Shanghai Co. Ltd. engages in the development of therapeutics for cancer, especially in immuno-oncology. The company is headquartered in Shanghai, China. | Biotechnology | Chief Executive Officer | |
Shenzhen Jingtai Technology Co., Ltd.
Shenzhen Jingtai Technology Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shenzhen Jingtai Technology Co., Ltd. is a company that researches and develops biotechnology products. The company is based in Shenzhen, China. The Chinese company was founded in 2015 by Shu Hao Wen, Jian Ma, Li Peng Lai. Jian Ma has been the CEO since 2015. | Miscellaneous Commercial Services | Director/Board Member | |
JW Therapeutics (Shanghai) Co., Ltd.
JW Therapeutics (Shanghai) Co., Ltd. BiotechnologyHealth Technology JW Therapeutics (Shanghai) Co., Ltd. engages in biopharmaceutical industry. It focuses on the development, transformation, and promotion of cell-based immunotherapies to treat cancer. The company was founded by Yi Ping Li on February 18, 2016 and is headquartered in Shanghai, China. | Biotechnology | Chief Tech/Sci/R&D Officer | |
NuProbe USA, Inc.
NuProbe USA, Inc. Miscellaneous Commercial ServicesCommercial Services NuProbe USA, Inc. engages in the development of ultra-sensitive and multiplexed platform with reagents for non-invasive nucleic acid profiling and diagnostics. The firm offers VarTrace EGFR Assay, VarTrace BFAR Assay, and VarTrace AML multi-gene panel. The company was founded by Peng Yin, David Yu Zhang, and Victor Chenyang Shi in 2016 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member | |
Refuge Biotechnologies, Inc.
Refuge Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Refuge Biotechnologies, Inc. develops therapeutic cells. It is leveraging gene engineering technologies known as CRISPR interference (CRISPRi) and CRISPR activation (CRISPRa) to develop therapeutic cells that are programmed to make decisions inside the patient’s body. The firms programs include RB-1916, RB-H21 and RB-M1. The company was founded by Stanley Qi, David R. Parkinson and Bing C. Wang and is headquartered in Menlo Park, CA. | Miscellaneous Commercial Services | Director/Board Member | |
FRONTAGE HOLDINGS CORPORATION | Biotechnology | Director/Board Member | |
Sanofi (China) Investment Co. Ltd. | Corporate Officer/Principal | ||
JW (CAYMAN) THERAPEUTICS CO. LTD | Biotechnology | Chief Tech/Sci/R&D Officer | |
ENLIVEX THERAPEUTICS LTD. | Biotechnology | Director/Board Member | |
Acepodia Biotechnologies, Ltd.
Acepodia Biotechnologies, Ltd. BiotechnologyHealth Technology Acepodia Biotechnologies, Ltd. engages in the development of cell therapies to treat patients with cancers. Its business information includes biotechnology service industry, intellectual property rights, and wholesale and retail trade of chemical raw materials. The company was founded by Patrick Yang, and by Sonny Hsiao on June 19, 2017 and is headquartered in Taipei, Taiwan. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Insilico Medicine Cayman TopCo
Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong. | Miscellaneous Commercial Services | Director/Board Member | |
HBM HOLDINGS LIMITED | Pharmaceuticals: Other | Chief Executive Officer | |
Taizhou EOC Pharma Co., Ltd.
Taizhou EOC Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Taizhou EOC Pharma Co., Ltd. engages in the research and development, and sale of drugs for tumor treatment. Its business segments include clinical trial research, pharmaceutical production, drug discovery and product introduction, drug registration, and product sales and commercialization. Its Clinical Trial Research segment involves in the clinical plan formulation, patient inclusion and exclusion criteria design, and primary and secondary endpoint indicators selection. Its Pharmaceutical Production segment supplies entinostat clinical trial drugs. Its Drug Discovery and Product Introduction segment implements drug discovery and research. Its Drug Registration segment manages product registration with drug regulatory department. Its Product Sales and Commercialization segment offers pharmaceutical academic promotion and sales agency assistance for pharmaceutical companies. The company was founded by Xin Ni and Xiao Ming Zou on October 21, 2010 and is headquartered in Taizhou, China. | Pharmaceuticals: Major | Director/Board Member | |
STRUCTURE THERAPEUTICS INC. | Miscellaneous Commercial Services | Director/Board Member | |
Wuhan Neurophth Biotechnology Co., Ltd.
Wuhan Neurophth Biotechnology Co., Ltd. BiotechnologyHealth Technology Wuhan Neurophth Biotechnology Co., Ltd. is a leading in-vivo gene therapy company for ophthalmic diseases based in Wuhan, China. The Chinese company's core product, nr082 (nfs-01), is designed to treat ND4-mediated Leber's hereditary optic neuropathy (ND4-LHON) and has been granted orphan drug designation (ODD) by the FDA and EMA. It is the first Chinese gene therapy new drug that has been granted IND approval for clinical trials by the Chinese National Medical Products Administration (NMPA) and the FDA. The company's pipeline also includes ND1-mediated LHON, autosomal dominant optic atrophy, optic nerve protection, vascular retinopathy, and other preclinical candidates. The company was founded in 2016 by Bin Li, Su Xiao, Dabo Cai, and Bin Li has been the CEO since then. | Biotechnology | Director/Board Member | |
Inceptor Bio LLC
Inceptor Bio LLC BiotechnologyHealth Technology Inceptor Bio LLC operates as a biotechnology industry company. The company is headquartered in Raleigh, NC. | Biotechnology | Director/Board Member | |
Hbm Suzhou Co. Ltd. | Chief Executive Officer | ||
Hbm Guangzhou | Chief Executive Officer | ||
INDAPTUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Verimmune, Inc.
Verimmune, Inc. BiotechnologyHealth Technology Verimmune, Inc. is a company based in Washington that is dedicated to developing a first-in-class cancer immunotherapy called anti-tumor immune redirection (AIR). Verimmune's proprietary virus-inspired particle (VIP) technology platform redirects pre-existing pathogenic or childhood vaccine immune memory toward tumors. The American company's lead immuno-oncology product candidate, Veri-101, harnesses the cellular immune memory responses from prior cytomegalovirus (CMV) infection to fight cancer. This mechanism of action has the potential to redefine the treatment paradigm for patients with untreatable cancers or resistance to existing therapies. The company was founded in 1995 by John Troyer and Joshua Weiyuan Wang, with Joshua Weiyuan Wang serving as the CEO since then. | Biotechnology | Director/Board Member | |
Aprinoia Therapeutics, Inc. /US/
Aprinoia Therapeutics, Inc. /US/ BiotechnologyHealth Technology Aprinoia Therapeutics, Inc. operates as a global clinical-stage biopharmaceutical company. It develops imaging diagnostic tools, targeted therapy drugs, and other products. The company was founded in 2015 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Silicon Therapeutics, Inc. | Chairman |
Statistiche
Distribuzione geografica
Stati Uniti | 28 |
Cina | 17 |
Isole Cayman | 3 |
Germania | 2 |
Irlanda | 2 |
Settori
Health Technology | 24 |
Consumer Services | 12 |
Commercial Services | 8 |
Health Services | 2 |
Finance | 2 |
Posizioni
Director/Board Member | 30 |
Corporate Officer/Principal | 15 |
Independent Dir/Board Member | 13 |
Chairman | 13 |
Chief Executive Officer | 7 |
Contatti più connessi
Insiders | |
---|---|
Roger Pomerantz | 30 |
Mark Gilbert | 13 |
Jing Song Wang | 12 |
Cui Ping Gu | 10 |
Lijun Sun | 8 |
Christopher Borella | 3 |
Elliot L. Chaikof | 2 |
Finith Jernigan | 1 |
- Borsa valori
- Insiders
- Peiqi Sun
- Connessioni Società